Genomic Health Director Buys More Than 128K Shares and 4 Insider Trades to Note

Baker Felix who is Director at Genomic Health Inc. (NASDAQ:GHDX), bought 128,341 shares at $36.69 per share for a total value of $4,708,433. The shares recently traded at $36.58, down $0.11, or 0.3% since the insider buy.

NEW! Discover a new stock idea each week for less than the cost of 1 trade. CLICK HERE for your Weekly Stock Cheat Sheets NOW!

GHDX

Bryant Monroe David Jr who is Director at Navarre Corp. (NASDAQ:NAVR), bought 20,000 shares at $2.37 per share for a total value of $47,400. The shares recently traded at $2.47, up $0.1, or 4.22% since the insider buy.

NEW! Discover a new stock idea each week for less than the cost of 1 trade. CLICK HERE for your Weekly Stock Cheat Sheets NOW!

NAVR

Mark Reuben who is Director at Cabela’s Inc. (NYSE:CAB), bought 5,000 shares at $66.50 per share for a total value of $332,500. The shares recently traded at $67.57, up $1.07, or 1.61% since the insider buy.

NEW! Discover a new stock idea each week for less than the cost of 1 trade. CLICK HERE for your Weekly Stock Cheat Sheets NOW!

CAB

Sennott John Langton Jr who is SVP, Chief Financial Officer at Alleghany Corp. (NYSE:Y), bought 300 shares at $381.90 per share for a total value of $114,570. The shares recently traded at $379.1, down $2.8, or 0.73% since the insider buy.

NEW! Discover a new stock idea each week for less than the cost of 1 trade. CLICK HERE for your Weekly Stock Cheat Sheets NOW!

Y

Hutchens James Justin who is CEO and President at National Health Investors Inc. (NYSE:NHI), bought 1,610 shares at $62.23 per share for a total value of $100,185. The shares recently traded at $63.1, up $0.87, or 1.4% since the insider buy.

NEW! Discover a new stock idea each week for less than the cost of 1 trade. CLICK HERE for your Weekly Stock Cheat Sheets NOW!

NHI

Investing Insights: Will UnitedHealth Group See Its Stock Surge Higher?